The death of 58-year-old nurse Susan McGowan has been linked to the recently approved weight-loss drug, tirzepatide, branded as Mounjaro, raising alarms about its safety. After taking two low-dose injections over two weeks, McGowan experienced severe complications leading to her death from multiple organ failure. Doctors noted her use of Mounjaro as a contributing factor. Despite its approval by UK health authorities, concerns persist regarding the drug’s risks versus benefits. The Medicines and Healthcare products Regulatory Agency emphasizes ongoing safety monitoring for such medications.